An increase in high-fat, high-fructose foods in people's diets has contributed to a dramatic increase in type 2 diabetes.

Vertex's Journavx got FDA approval for acute pain but faces adoption challenges. Click here to read more about VRTX stock and ...

The nonaddictive painkiller suzetrigine (Journavx) is as effective for acute pain as a common opioid treatment ...

Oxford Cannabinoid Technologies is shedding its old skin. Having delisted its stock last year, the biotech is rebranding as ...

For the first time in decades, a new class of painkiller has been approved by the US Food and Drug Administration (FDA).

Finding Relief from Peripheral Neuropathy Without Medication Peripheral neuropathy can bring persistent pain, numbness, and ...

Understanding the risks, symptoms, and prevention methods for diabetic foot conditions is crucial for those with diabetes.

The FDA recently approved Vertex Pharmaceuticals Incorporated’s Journavx (suzetrigine), a first-in-class non-opioid ...